Cargando…
IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models
Pancreatic ductal adenocarcinoma (PDAC) and cancer-associated cachexia (CAC) are multifactorial and characterized by dysregulated inflammatory networks. Whether the proinflammatory cytokine IL-20 is involved in the complex networks of PDAC and CAC remains unclear. Here, we report that elevated IL-20...
Autores principales: | Lu, Shao-Wei, Pan, Hong-Chin, Hsu, Yu-Hsiang, Chang, Kung-Chao, Wu, Li-Wha, Chen, Wei-Yu, Chang, Ming-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490368/ https://www.ncbi.nlm.nih.gov/pubmed/32929072 http://dx.doi.org/10.1038/s41467-020-18244-8 |
Ejemplares similares
-
Anti-IL-20 Monoclonal Antibody Suppresses Prostate Cancer Growth and Bone Osteolysis in Murine Models
por: Hsu, Yu-Hsiang, et al.
Publicado: (2015) -
IL-20 bone diseases involvement and therapeutic target potential
por: Wang, Hsiao-Hsuan, et al.
Publicado: (2018) -
Anti-IL-20 monoclonal antibody promotes bone fracture healing through regulating IL-20-mediated osteoblastogenesis
por: Hsu, Yu-Hsiang, et al.
Publicado: (2016) -
Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis
por: Hsu, Yu-Hsiang, et al.
Publicado: (2017) -
The roles of IL-19 and IL-20 in the inflammation of degenerative lumbar spondylolisthesis
por: Huang, Kuo-Yuan, et al.
Publicado: (2018)